1-6 of 6
Li Dong
Close
Sort by
Journal Articles

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma, Shuhong Shen, Yingchi Zhang, Yongjin Li, Karol Szlachta, Li Dong, Yu Liu, Fan Yang, Ningling Wang, Diane A. Flasch, Matthew A. Myers, Heather L. Mulder, Lixia Ding, Yanling Liu, Liqing Tian, Kohei Hagiwara, Ke Xu, Xin Zhou, Edgar Sioson, Tianyi Wang, Liu Yang, Jie Zhao, Hui Zhang, Ying Shao, Hongye Sun, Lele Sun, Jiaoyang Cai, Hui-Ying Sun, Ting-Nien Lin, Lijuan Du, Hui Li, Michael Rusch, Michael N. Edmonson, John Easton, Xiaofan Zhu, Jingliao Zhang, Cheng Cheng, Benjamin J. Raphael, Jingyan Tang, James R. Downing, Ludmil B. Alexandrov, Bin-Bing S. Zhou, Ching-Hon Pui, Jun J. Yang, Jinghui Zhang
Journal: Blood
Blood (2020) 135 (1): 41–55.
https://doi.org/10.1182/blood.2019002220
Published: 2020
Includes: Supplemental data
Journal Articles

Incidence of Germline Mutations in Cancer-Predisposition Genes in Children with Hematologic Malignancies: a Report from the Pediatric Cancer Genome Project

Michael Walsh, MD, Gang Wu, PhD, Michael Edmonson, PhD, Tanja A Gruber, MD PhD, John Easton, PhD, Donald Yergeau, PhD, Bhavin Vadodaria, BA, Xiaotu Ma, PhD, Xiang Chen, PhD, Rose McGee, MS, CGC, Christine Odom, MS, CGC, Sheila A Shurtleff, PhD, Matthew Parker, PhD, Michael Rusch, BA, Erin Hedlund, PhD, Robert Huether, PhD, Gordon Lemmon, PhD, Joy Nakitandwe, PhD, Jared Becksfort, MS, Panduka Nagahawatte, MS, Li Dong, PhD, Amanda Larson Gedman, PhD, Zachary J Faber, PhD, Jinjun Cheng, MD PhD, Jinjun Dang, PhD, Ching-Hon Pui, MD, Kim E Nichols, MD, Amar Gajjar, MD, David W Ellison, MD, Alberto Pappo, MD, Charles G. Mullighan, MBBS, MSc, MD, Elaine R Mardis, PhD, Richard K Wilson, PhD, Jinghui Zhang, PhD, James R Downing, MD
Journal: Blood
Blood (2014) 124 (21): 127.
https://doi.org/10.1182/blood.V124.21.127.127
Published: 2014
Journal Articles

Daily C - Reactive Protein (CRP) Levels Allow Early Identification of Patients with Severe Complications after Melphalan (MEL) and Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM).

Elias J. Anaissie, MD, Monica L. Grazziutti, MD, Athanasios Fassas, MD, Li Dong, MD, Miceli H. Miceli, MD, Frits Van Rhee, MD, PhD, Klaus A. Hollmig, MD, Giampaolo Talamo, MD, Guido J. Tricot, MD, Bart Barlogie, MD
Journal: Blood
Blood (2004) 104 (11): 5040.
https://doi.org/10.1182/blood.V104.11.5040.5040
Published: 2004
Journal Articles

Increased Bone Marrow Iron Stores, Severe Mucositis and Large Area under the Curve (AUC) of Profound Neutropenia Predict Severe Infection in 382 Myeloma Patients Undergoing Melphalan - Autologous Stem Cell Transplantation (MEL-ASCT).

Elias J. Anaissie, MD, Marisa H. Miceli, MD, Li Dong, MD,MS, Monica L. Grazziutti, MD, Sabitha Rajan, Giampaolo Talamo, MD, Raymond Thertulien, MD, PhD, Anasthasios Fassas, MD, Guido Tricot, MD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1158.
https://doi.org/10.1182/blood.V104.11.1158.1158
Published: 2004
Journal Articles

Safety of Total Therapy III for Newly Diagnosed Multiple Myeloma: Preliminary Analysis of 62 Consecutive Patients.

Elias J. Anaissie, MD, Marisa H. Miceli, MD, Li Dong, MD, MS, Fariba Saghafifar, MD, Giampaolo Talamo, MD, Klaus A. Hollmig, MD, Guido Tricot, MD, Bart Barlogie, MD, PhD.
Journal: Blood
Blood (2004) 104 (11): 935.
https://doi.org/10.1182/blood.V104.11.935.935
Published: 2004
Journal Articles

Avascular Necrosis of Bone after Therapy for Multiple Myeloma: A Study of 561 Consecutive Patients.

Elias J. Anaissie, MD, Giampaolo Talamo, MD, Edgardo Angtuaco, MD, Ronald C. Walker, MD, Li Dong, MD, MS, Maurizio Zangari, MD, Guido Tricot, MD, Bart Barlogie, MD, PhD.
Journal: Blood
Blood (2004) 104 (11): 3467.
https://doi.org/10.1182/blood.V104.11.3467.3467
Published: 2004